1 North Wealth Services’s Regeneron Pharmaceuticals REGN Stock Holding History

1 North Wealth Services’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1K	Hold	3	–	–	﹤0.01%	302
2018 Q4	$1K	Buy	+3	New	+$1.1K	﹤0.01%	282

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1 North Wealth Services's REGN Position: Q1 2019 in Review

1 North Wealth Services held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2019 at 3 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #302.

1 North Wealth Services first reported a position in REGN in Q4 2018 and has held it in 2 quarters since. 718 funds tracked by Wall St. Rank hold REGN as of Q1 2019.

1 North Wealth Services held 3 shares of Regeneron Pharmaceuticals worth $1K as of Q1 2019.
1 North Wealth Services left its Regeneron Pharmaceuticals share count unchanged in Q1 2019.
Regeneron Pharmaceuticals made up ﹤0.01% of 1 North Wealth Services's portfolio in Q1 2019, its #302 holding.
1 North Wealth Services first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 2 quarters since.
718 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2019.

Based on 1 North Wealth Services's 13F filing for Q1 2019, filed 8 May 2019.